tirzepatide peptide research only Peptide GLP1 – Tirz (10-20mg) |
Description
Approved in April 2026, it recorded effective weight reduction in clinical trials, with an average 12.4% body weight loss among participants
Of these, 24 participants completed the trial
Weight loss and blood sugar improvements may temporarily plateau or fluctuate during the adjustment period
Importantly, the infusions were well tolerated and did not trigger any adverse effects (30)
